Evidence map›Paper›PMID 24811761›Full record

ArticleOncotarget2014

Hyperactivation of Alk induces neonatal lethality in knock-in AlkF1178L mice.

Lucille Lopez-Delisle, Cécile Pierre-Eugène, Evelyne Bloch-Gallego, Marie-Christine Birling, Jean-Loup Duband, Estelle Durand, Thomas Bourgeois, Boris Matrot, Tania Sorg, Michel Huerre and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Lucille Lopez-DelisleInserm U830, Paris, France;
Cécile Pierre-Eugène
Evelyne Bloch-Gallego
Marie-Christine Birling
Jean-Loup Duband
Estelle Durand
Thomas Bourgeois
Boris Matrot
Tania Sorg
Michel Huerre
Hamid Meziane
Michel J Roux
Marie-France Champy
Jorge Gallego
Olivier Delattre
Isabelle Janoueix-Lerosey
Institut Clinique de la Souris · FRInserm · FRInstitut Curie · FRCentre National de la Recherche Scientifique · FRHôpital Robert-Debré · FRInstitut Cochin · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ALK (Anaplastic Lymphoma Kinase) gene encodes a tyrosine kinase receptor preferentially expressed in the central and peripheral nervous systems. A syndromic presentation associating congenital neuroblastoma with severe encephalopathy and an abnormal shape of the brainstem has been described in patients harbouring de novo germline F1174V and F1245V ALK mutations. Here, we investigated the phenotype of knock-in (KI) mice bearing the AlkF1178L mutation (F1174L in human). Although heterozygous KI mice did not reproduce the severe breathing and feeding difficulties observed in human patients, behavioral tests documented a reduced activity during dark phases and an increased anxiety of mutated mice. Matings of heterozygotes yielded the expected proportions of wild-type, heterozygotes and homozygotes at birth but a high neonatal lethality was noticed for homozygotes. We documented Alk expression in several motor nuclei of the brainstem involved in the control of sucking and swallowing. Evaluation of basic physiological functions 12 hours after birth revealed slightly more apneas but a dramatic reduced milk intake for homozygotes compared to control littermates. Overall, our data demonstrate that Alk activation above a critical threshold is not compatible with survival in mice, in agreement with the extremely severe phenotype of patients carrying aggressive de novo ALK germline mutations.

Indexed as

EatingRespirationAnaplastic Lymphoma KinaseAnimalsAnimals, NewbornBehavior, AnimalGenes, LethalHumansImmunoenzyme TechniquesMaleMiceMutationNeuroblastomaPhenotypeReceptor Protein-Tyrosine KinasesALK protein, humanAlk protein, mouseAnaplastic Lymphoma KinaseReceptor Protein-Tyrosine Kinases

Identifiers

PMID24811761
PMCPMC4058038
OpenAlexW1503699712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.